Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
Not Confirmed
Not Confirmed
06-10 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Industry Trade Show
Not Confirmed
06-10 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
03 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/erbc-and-menarini-biotech-join-forces-to-accelerate-the-development-of-biopharmaceuticals-from-research-to-first-in-human-clinical-trials-302419863.html
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046229/21662/en/Menarini-Group-Announces-Collaboration-with-VisualDx-to-Aid-in-Identifying-People-Who-May-Have-Blastic-Plasmacytoid-Dendritic-Cell-Neoplasm-BPDCN.html
10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-group-and-insilico-medicine-enter-a-second-exclusive-global-license-agreement-for-an-ai-discovered-preclinical-asset-targeting-high-unmet-needs-in-oncology-302348075.html
16 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-group-announces-positive-topline-data-from-pivotal-phase-3-broadway--tandem-clinical-trials-evaluating-obicetrapib-and-the-fixed-dose-combination-obicetrapib-with-ezetimibe-10-mg-302332562.html
12 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-group-and-medsir-present-the-phase-iii-study-adela-a-new-therapeutic-strategy-for-advanced-breast-cancer-302330037.html
11 Dec 2024
// BUSINESSWIRE
ABOUT THIS PAGE